Rockefeller Financial Services’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-8,444
Closed -$132K 502
2015
Q1
$132K Buy
8,444
+2,747
+48% +$42.5K ﹤0.01% 351
2014
Q4
$87K Sell
5,697
-1,380
-19% -$16.8K ﹤0.01% 364
2014
Q3
$76K Sell
7,077
-7,091
-50% -$92.6K ﹤0.01% 387
2014
Q2
$216K Hold
14,168
﹤0.01% 331
2014
Q1
$256K Buy
14,168
+502
+4% +$9.68K 0.01% 318
2013
Q4
$190K Buy
13,666
+122
+0.9% +$1.41K ﹤0.01% 350
2013
Q3
$142K Buy
+13,544
New +$135K ﹤0.01% 361

Other funds holding SGMO

Rockefeller Financial Services's SGMO Position: Q2 2015 in Review

Rockefeller Financial Services sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2015, closing a stake of 8,444 shares — an estimated $132K sold.

Rockefeller Financial Services first reported a position in SGMO in Q3 2013 and held it in 7 quarters. The position peaked at $256K in Q1 2014. 156 funds tracked by Wall St. Rank hold SGMO as of Q2 2015.

  • Rockefeller Financial Services reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2015 after selling out during the quarter.
  • Rockefeller Financial Services sold 8,444 SANGAMO THERAPEUTICS INC shares in Q2 2015, an estimated $132K.
  • Rockefeller Financial Services first reported a position in SANGAMO THERAPEUTICS INC in Q3 2013 and held it in 7 quarters.
  • Rockefeller Financial Services's SANGAMO THERAPEUTICS INC position peaked at $256K in Q1 2014.
  • 156 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2015.

Based on Rockefeller Financial Services's 13F filing for Q2 2015, filed 14 Jul 2015.